Completed biopharma M&As, including: Asahi Kasei, Axim, Danaher, Domain, Foamix, GE Healthcare, Menlo, Neurofit, Prestwick Chemical, Psilocin, Recode, Revive, Sapphire, Transcriptx, Veloxis.